O	0	3	The	The	DT	B-NP
O	4	7	Akt	Akt	NN	I-NP
O	7	8	/	/	SYM	B-VP
O	8	12	mTOR	mTOR	NN	B-NP
O	13	20	pathway	pathway	NN	I-NP
O	21	28	assures	assure	VBZ	B-VP
O	29	32	the	the	DT	B-NP
O	33	42	synthesis	synthesis	NN	I-NP
O	43	45	of	of	IN	B-PP
O	46	49	HIF	HIF	NN	B-NP
O	49	50	-	-	HYPH	B-NP
O	50	56	1alpha	1alpha	NN	I-NP
O	57	64	protein	protein	NN	I-NP
O	65	67	in	in	IN	B-PP
O	68	69	a	a	DT	B-NP
O	70	77	glucose	glucose	NN	I-NP
O	77	78	-	-	HYPH	B-NP
O	79	82	and	and	CC	I-NP
O	83	96	reoxygenation	reoxygenation	NN	I-NP
O	96	97	-	-	HYPH	I-NP
O	97	106	dependent	dependent	JJ	I-NP
O	107	113	manner	manner	NN	I-NP
O	114	116	in	in	IN	B-PP
O	117	127	irradiated	irradiated	JJ	B-NP
B-Cancer	128	134	tumors	tumor	NNS	I-NP
O	134	135	.	.	.	O

O	137	152	Transcriptional	Transcriptional	JJ	B-NP
O	153	161	activity	activity	NN	I-NP
O	162	164	of	of	IN	B-PP
O	165	168	HIF	HIF	NN	B-NP
O	168	169	-	-	HYPH	B-NP
O	169	170	1	1	CD	I-NP
O	171	172	(	(	(	O
O	172	179	hypoxia	hypoxia	NN	B-NP
O	179	180	-	-	HYPH	O
O	180	189	inducible	inducible	JJ	B-NP
O	190	196	factor	factor	NN	I-NP
O	196	197	-	-	HYPH	B-NP
O	197	198	1	1	CD	I-NP
O	198	199	)	)	)	O
O	200	203	has	have	VBZ	B-VP
O	204	208	been	be	VBN	I-VP
O	209	217	reported	report	VBN	I-VP
O	218	220	to	to	TO	I-VP
O	221	223	be	be	VB	I-VP
O	224	226	up	up	RB	B-ADVP
O	226	227	-	-	HYPH	B-NP
O	227	236	regulated	regulate	VBN	B-VP
O	237	239	in	in	IN	B-PP
B-Cancer	240	245	solid	solid	JJ	B-NP
I-Cancer	246	252	tumors	tumor	NNS	I-NP
O	253	258	after	after	IN	B-PP
O	259	267	ionizing	ionize	VBG	B-VP
O	268	277	radiation	radiation	NN	B-NP
O	277	278	;	;	:	O
O	279	286	however	however	RB	B-ADVP
O	286	287	,	,	,	O
O	288	291	the	the	DT	B-NP
O	292	301	molecular	molecular	JJ	I-NP
O	302	311	mechanism	mechanism	NN	I-NP
O	312	322	underlying	underlie	VBG	B-VP
O	323	326	the	the	DT	B-NP
O	327	335	response	response	NN	I-NP
O	336	343	remains	remain	VBZ	B-VP
O	344	346	to	to	TO	I-VP
O	347	349	be	be	VB	I-VP
O	350	360	elucidated	elucidate	VBN	I-VP
O	360	361	.	.	.	O

O	362	364	In	In	IN	B-PP
O	365	368	the	the	DT	B-NP
O	369	376	present	present	JJ	I-NP
O	377	382	study	study	NN	I-NP
O	382	383	,	,	,	O
O	384	386	we	we	PRP	B-NP
O	387	396	performed	perform	VBD	B-VP
O	397	398	a	a	DT	B-NP
O	399	405	series	series	NN	I-NP
O	406	408	of	of	IN	B-PP
O	409	418	molecular	molecular	JJ	B-NP
O	419	426	imaging	imaging	NN	I-NP
O	427	438	experiments	experiment	NNS	I-NP
O	439	444	using	use	VBG	B-VP
O	445	446	a	a	DT	B-NP
O	447	450	HIF	HIF	NN	I-NP
O	450	451	-	-	HYPH	B-NP
O	451	452	1	1	CD	I-NP
O	452	453	-	-	HYPH	I-NP
O	453	462	dependent	dependent	JJ	I-NP
O	463	471	reporter	reporter	NN	I-NP
O	472	476	gene	gene	NN	I-NP
O	476	477	,	,	,	O
O	478	483	5HREp	5HREp	NN	B-NP
O	483	484	-	-	HYPH	B-NP
O	484	487	ODD	ODD	NN	I-NP
O	487	488	-	-	HYPH	B-NP
O	488	491	luc	luc	NN	I-NP
O	491	492	,	,	,	O
O	493	496	and	and	CC	O
O	497	502	found	find	VBD	B-VP
O	503	505	an	an	DT	B-NP
O	506	515	essential	essential	JJ	I-NP
O	516	520	role	role	NN	I-NP
O	521	523	of	of	IN	B-PP
O	524	527	the	the	DT	B-NP
O	528	531	Akt	Akt	NN	I-NP
O	531	532	/	/	SYM	B-NP
O	532	536	mTOR	mTOR	NN	I-NP
O	537	544	pathway	pathway	NN	I-NP
O	544	545	.	.	.	O

O	546	553	Hypoxic	Hypoxic	JJ	B-NP
B-Cell	554	559	tumor	tumor	NN	I-NP
I-Cell	560	565	cells	cell	NNS	I-NP
O	566	573	distant	distant	JJ	B-ADJP
O	574	578	from	from	IN	B-PP
B-Multi-tissue_structure	579	584	blood	blood	NN	B-NP
I-Multi-tissue_structure	585	592	vessels	vessel	NNS	I-NP
O	593	597	were	be	VBD	B-VP
O	598	610	dramatically	dramatically	RB	I-VP
O	611	623	reoxygenated	reoxygenate	VBN	I-VP
O	624	626	at	at	IN	B-PP
O	627	629	24	24	CD	B-NP
O	630	631	h	h	NN	I-NP
O	632	647	postirradiation	postirradiation	NN	I-NP
O	647	648	,	,	,	O
O	649	652	and	and	CC	O
O	653	656	HIF	HIF	NN	B-NP
O	656	657	-	-	HYPH	B-NP
O	657	658	1	1	CD	I-NP
O	659	667	activity	activity	NN	I-NP
O	668	677	increased	increase	VBD	B-VP
O	678	680	as	as	IN	B-SBAR
O	681	684	HIF	HIF	NN	B-NP
O	684	685	-	-	HYPH	I-NP
O	685	691	1alpha	1alpha	NN	I-NP
O	692	703	accumulated	accumulate	VBN	B-VP
O	704	706	in	in	IN	B-PP
O	707	710	the	the	DT	B-NP
O	711	723	reoxygenated	reoxygenate	VBN	I-NP
O	724	731	regions	region	NNS	I-NP
O	731	732	.	.	.	O

O	733	736	The	The	DT	B-NP
O	737	749	accumulation	accumulation	NN	I-NP
O	750	753	was	be	VBD	B-VP
O	754	763	inhibited	inhibit	VBN	I-VP
O	764	768	with	with	IN	B-PP
O	769	770	a	a	DT	B-NP
O	771	787	nonmetabolizable	nonmetabolizable	JJ	I-NP
O	788	795	glucose	glucose	NN	I-NP
O	796	802	analog	analog	NN	I-NP
O	802	803	,	,	,	O
O	804	805	2	2	CD	B-NP
O	805	806	-	-	HYPH	I-NP
O	806	811	deoxy	deoxy	NN	I-NP
O	811	812	-	-	HYPH	B-NP
O	812	813	d	d	NN	I-NP
O	813	814	-	-	HYPH	I-NP
O	814	821	glucose	glucose	NN	I-NP
O	821	822	,	,	,	O
O	823	830	through	through	IN	B-PP
O	831	834	the	the	DT	B-NP
O	835	846	suppression	suppression	NN	I-NP
O	847	849	of	of	IN	B-PP
O	850	859	radiation	radiation	NN	B-NP
O	859	860	-	-	HYPH	B-NP
O	860	867	induced	induce	VBN	I-NP
O	868	883	phosphorylation	phosphorylation	NN	I-NP
O	884	886	of	of	IN	B-PP
O	887	890	Akt	Akt	NN	B-NP
O	891	893	in	in	IN	B-PP
O	894	897	the	the	DT	B-NP
O	898	910	reoxygenated	reoxygenate	VBN	I-NP
O	911	918	regions	region	NNS	I-NP
O	918	919	.	.	.	O

O	920	923	Akt	Akt	NN	B-NP
O	924	933	knockdown	knockdown	NN	I-NP
O	934	937	and	and	CC	O
O	938	940	an	an	DT	B-NP
O	941	945	mTOR	mTOR	NN	I-NP
O	946	955	inhibitor	inhibitor	NN	I-NP
O	956	964	revealed	reveal	VBD	B-VP
O	965	968	the	the	DT	B-NP
O	969	979	importance	importance	NN	I-NP
O	980	982	of	of	IN	B-PP
O	983	986	the	the	DT	B-NP
O	987	990	Akt	Akt	NN	I-NP
O	990	991	/	/	SYM	B-NP
O	991	995	mTOR	mTOR	NN	I-NP
O	996	1003	pathway	pathway	NN	I-NP
O	1004	1006	in	in	IN	B-PP
O	1007	1010	the	the	DT	B-NP
O	1011	1026	postirradiation	postirradiation	NN	I-NP
O	1027	1039	accumulation	accumulation	NN	I-NP
O	1040	1042	of	of	IN	B-PP
O	1043	1046	HIF	HIF	NN	B-NP
O	1046	1047	-	-	HYPH	B-NP
O	1047	1053	1alpha	1alpha	NN	I-NP
O	1053	1054	.	.	.	O

O	1055	1057	In	In	FW	B-NP
O	1058	1063	vitro	vitro	FW	I-NP
O	1064	1075	experiments	experiment	NNS	I-NP
O	1076	1085	confirmed	confirm	VBD	B-VP
O	1086	1090	that	that	IN	B-SBAR
O	1091	1093	an	an	DT	B-NP
O	1094	1102	increase	increase	NN	I-NP
O	1103	1105	in	in	IN	B-PP
O	1106	1113	glucose	glucose	NN	B-NP
O	1114	1126	availability	availability	NN	I-NP
O	1127	1134	induced	induce	VBD	B-VP
O	1135	1138	Akt	Akt	NN	B-NP
O	1139	1154	phosphorylation	phosphorylation	NN	I-NP
O	1155	1160	under	under	IN	B-PP
O	1161	1173	reoxygenated	reoxygenate	VBN	B-NP
O	1174	1184	conditions	condition	NNS	I-NP
O	1185	1188	and	and	CC	O
O	1189	1201	consequently	consequently	RB	B-ADVP
O	1202	1204	up	up	RB	B-ADVP
O	1204	1205	-	-	HYPH	I-ADVP
O	1205	1214	regulated	regulate	VBN	B-NP
O	1215	1218	HIF	HIF	NN	I-NP
O	1218	1219	-	-	HYPH	B-NP
O	1219	1225	1alpha	1alpha	NN	I-NP
O	1226	1237	translation	translation	NN	I-NP
O	1237	1238	.	.	.	O

O	1239	1247	Moreover	Moreover	RB	B-ADVP
O	1247	1248	,	,	,	O
O	1249	1253	both	both	CC	O
O	1254	1257	the	the	DT	B-NP
O	1258	1269	accelerated	accelerate	VBN	I-NP
O	1270	1281	translation	translation	NN	I-NP
O	1282	1285	and	and	CC	O
O	1286	1289	the	the	DT	B-NP
O	1290	1300	previously	previously	RB	I-NP
O	1301	1309	reported	report	VBN	I-NP
O	1310	1318	reactive	reactive	JJ	I-NP
O	1319	1325	oxygen	oxygen	NN	I-NP
O	1326	1333	species	species	NN	I-NP
O	1333	1334	-	-	HYPH	B-VP
O	1334	1342	mediated	mediate	VBN	B-NP
O	1343	1356	stabilization	stabilization	NN	I-NP
O	1357	1359	of	of	IN	B-PP
O	1360	1363	HIF	HIF	NN	B-NP
O	1363	1364	-	-	HYPH	B-NP
O	1364	1370	1alpha	1alpha	NN	I-NP
O	1371	1378	protein	protein	NN	I-NP
O	1379	1383	were	be	VBD	B-VP
O	1384	1393	essential	essential	JJ	B-ADJP
O	1394	1396	to	to	TO	B-PP
O	1397	1400	the	the	DT	B-NP
O	1401	1411	activation	activation	NN	I-NP
O	1412	1414	of	of	IN	B-PP
O	1415	1418	HIF	HIF	NN	B-NP
O	1418	1419	-	-	HYPH	B-NP
O	1419	1420	1	1	CD	I-NP
O	1420	1421	.	.	.	O

O	1422	1425	All	All	DT	B-NP
O	1426	1428	of	of	IN	B-PP
O	1429	1434	these	these	DT	B-NP
O	1435	1442	results	result	NNS	I-NP
O	1443	1451	indicate	indicate	VBP	B-VP
O	1452	1456	that	that	IN	B-SBAR
O	1457	1460	Akt	Akt	NN	B-NP
O	1460	1461	/	/	SYM	B-NP
O	1461	1465	mTOR	mTOR	NN	I-NP
O	1465	1466	-	-	HYPH	B-NP
O	1466	1475	dependent	dependent	JJ	I-NP
O	1476	1487	translation	translation	NN	I-NP
O	1488	1490	of	of	IN	B-PP
O	1491	1494	HIF	HIF	NN	B-NP
O	1494	1495	-	-	HYPH	B-NP
O	1495	1501	1alpha	1alpha	NN	I-NP
O	1502	1507	plays	play	VBZ	B-VP
O	1508	1509	a	a	DT	B-NP
O	1510	1518	critical	critical	JJ	I-NP
O	1519	1523	role	role	NN	I-NP
O	1524	1526	in	in	IN	B-PP
O	1527	1530	the	the	DT	B-NP
O	1531	1546	postirradiation	postirradiation	NN	I-NP
O	1547	1549	up	up	RB	B-ADVP
O	1549	1550	-	-	HYPH	B-NP
O	1550	1560	regulation	regulation	NN	I-NP
O	1561	1563	of	of	IN	B-PP
B-Cancer	1564	1576	intratumoral	intratumoral	JJ	B-NP
O	1577	1580	HIF	HIF	NN	I-NP
O	1580	1581	-	-	HYPH	B-NP
O	1581	1582	1	1	CD	I-NP
O	1583	1591	activity	activity	NN	I-NP
O	1592	1594	in	in	IN	B-PP
O	1595	1603	response	response	NN	B-NP
O	1604	1606	to	to	TO	B-PP
O	1607	1616	radiation	radiation	NN	B-NP
O	1616	1617	-	-	HYPH	B-NP
O	1617	1624	induced	induce	VBN	I-NP
O	1625	1636	alterations	alteration	NNS	I-NP
O	1637	1639	of	of	IN	B-PP
O	1640	1647	glucose	glucose	NN	B-NP
O	1648	1651	and	and	CC	I-NP
O	1652	1658	oxygen	oxygen	NN	I-NP
O	1659	1671	availability	availability	NN	I-NP
O	1672	1674	in	in	IN	B-PP
O	1675	1676	a	a	DT	B-NP
B-Cancer	1677	1682	solid	solid	JJ	I-NP
I-Cancer	1683	1688	tumor	tumor	NN	I-NP
O	1688	1689	.	.	.	O

